Kenneth Warrington is a Sr. Manager Technical Evaluation at Made Scientific. He possess expertise in laboratory, molecular diagnostics, gene therapy, cgmp manufacturing, molecular pharmacology and 20 more skills. Colleagues describe him as "Ken is the consummate professional. While a scientist true at heart, he has the personality and technical savvy to excel from the bench level to prospecting with new accounts. This combination is a rare thing in today's Pharma industry I would highly recommend Ken for any Business Development or Senior Scientific roles.", "I worked with Ken for five years as he managed our Virology group and eventually transitioned into coordinating much of our business development activities specifically related to contract manufacturing. Ken is an excellent scientist capable of both 'seeing the big picture' and technically executing complex processes. Ken led the efforts involved with production of a virus-like protein vaccine in a baculovirus system, viral vector therapeutics, multiple wild-type vaccines and a series of virus challenge stocks. Ken's leadership of these projects was invaluable and recognized throughout the organization. His transition into the business development area recognized his project management capabilities, interpersonal 'people' skills and technical acumen. Ken was able to design, present and close multiple projects with an aggregate value of several million dollars. Our clients felt comfortable dealing with Ken due to the trust he built with them and their confidence in the technical understanding he brought to the project. I recommend Ken Warrington based on my over 5 years of experience in observing his performance in the areas of virology, business development and project management.", and "I worked with Ken on multiple, innovative vector production projects for several years and have maintained a professional relationship for over 10 years. Ken is able to move seamlessly from concept to commercialization and from patent to production, essential components of all biotechnology research and development. Ken is reliable, dedicated, and enthusiastic about new ideas and new process improvements that can improve knowledge or increase market share."